Fortuna Health
Fortuna Health
About Fortuna Health
At Fortuna Health, we’re rebuilding the consumer experience Medicaid. We believe that fixing the front door to public health benefits is one of the most urgent product challenges of our time - and that great design and infrastructure can unlock access, efficiency, and autonomy for millions.
Pitch deck breakdown
How Fortuna Health would pitch themselves.
Target customer
Business teams looking for modern saas tooling — replacing legacy software or building net-new workflows in this category.
Problem they solve
At Fortuna Health, we’re rebuilding the consumer experience Medicaid. We believe that fixing the front door to public health benefits is one of the most urgent product challenges of our time - and that great design and… The category has historically been served by tools that miss the modern workflow this product is built around.
Key differentiator
Fortuna Health differentiates on fortuna health. $0 raised — the company has resources + validation to compound this thesis.
Go-to-market strategy
Series-A scaling stage — building outbound sales motion, hiring first AEs, layering on customer success. Mix of PLG (where the product allows) + direct sales for higher-ACV deals.
Fortuna Health website preview
Company facts
- Category
- SaaS
- Funding stage
- Series A
- Total raised
- $0
- Founded
- 2020
- Team size
- 11–50
- HQ
- New York, United States
- Country
- United States
- Website
- fortunahealth.com
Frequently asked questions
What does Fortuna Health do?
At Fortuna Health, we’re rebuilding the consumer experience Medicaid. We believe that fixing the front door to public health benefits is one of the most urgent product challenges of our time - and that great design and infrastructure can unlock access, efficiency, and autonomy for millions.
Where is Fortuna Health based?
Fortuna Health is based in New York, United States, United States.
When was Fortuna Health founded?
Fortuna Health was founded in 2020.
How much has Fortuna Health raised?
Fortuna Health has raised $0 in their Series A round.